Semaglutide linked to slowed epigenetic ageing markers in randomised trial of adults with HIV
Semaglutide reduced epigenetic ageing across multiple clocks including PhenoAge by 4.9 years per year and DunedinPACE by 0.09 units in a 32-week trial.
14 JUL
· 2 min read
